美国 · 股市与财经 · TheStreet
This Mid-Cap Biotech’s Pullback Just Created a Trade I Can’t Ignore
The stock has fallen about 15% from its October highs. My strategy offers both double-digit upside potential and downside protection.
在 TheStreet 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (pro.thestreet.com)





